Substituted pyrazole, pyrrole and triazole angiotensin-II-1 receptor antagonists and pharmaceutically acceptable salts thereof are useful for treating central nervous system disorders, such as cognitive and learning disorders, mediated by angiotensin-II.
Treatment of central nervous system disorders with pyrazole, pyrrole and triazole angiotensin-II receptor antagonists